Paying For Placebo Is ‘Biggest Change’ In Medicare CED Policy, Official Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The director of Medicare’s coverage group sees the ability to pay physicians for providing a placebo in clinical trials required under a ‘coverage with evidence development’ determination as a major improvement in its recent guidance for CED.